Transgene S.A.
TNG
Classifica tra le azioni
#17721
Transgene SA, a French biotechnology firm headquartered in... Transgene SA, a French biotechnology firm headquartered in Illkirch-Graffenstaden, specializes in designing and developing groundbreaking therapeutic vaccines and oncolytic viruses to combat cancer and infectious diseases. Founded in 1979 and operating as a subsidiary of TSGH SAS, the company maintains a robust pipeline of treatments. This includes TG4050, a therapeutic vaccine in Phase I clinical trials for ovarian cancer and HPV-negative head and neck cancers, and TG4001, another therapeutic vaccine currently in Phase II for HPV-positive cancers. Its oncolytic virus programs feature TG6002, undergoing Phase I/IIa trials for various solid tumors, specifically gastrointestinal adenocarcinomas impacting the stomach, pancreas, and colon, as well as BT-001, an oncolytic virus in Phase I/II for solid tumors. Furthermore, Transgene is progressing TG1050, a therapeutic vaccine for chronic hepatitis B, and Pexa-Vec, an oncolytic virus targeting solid tumors. The company has established a comprehensive network of partnerships, encompassing strategic collaborations with major players like AstraZeneca, Merck KGaA, Pfizer, PersonGen BioTherapeutics, and NEC Corporation, alongside licensing agreements with SillaJen, Ascend BioPharmaceutical, and Valneva, and additional agreements with Sanofi, BioInvent, and Randox.
Prezzo delle azioni
$0.76140421
Capitalizzazione di mercato
$211.86M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-51.07%
Paese
FR
Scambia Transgene S.A. (TNG)
Categoria
Healthcare
Storico del prezzo dell'azione per Transgene S.A. (TNG)
Prezzo di chiusura più alto: $0.82 il 2026-10-01
Prezzo di chiusura più basso: $14.11 il 2008-11-01
Prezzo di chiusura più basso: $14.11 il 2008-11-01
Storico del prezzo dell'azione di Transgene S.A. dal 2008 al 2026
Andamento annuale del prezzo dell'azione
| Anno | Performance |
|---|---|
| 2026 (TTM) | -5.86% |
| 2025 | 46.53% |
| 2024 | -51.26% |
| 2023 | -19.91% |
| 2022 | -34.95% |
| 2021 | 38.48% |
| 2020 | 6.95% |
| 2019 | -36.75% |
| 2018 | -0.18% |
| 2017 | 11.12% |
| 2016 | -19.79% |
| 2015 | -61.06% |
| 2014 | -28.08% |
| 2013 | 15.30% |
| 2012 | 12.50% |
| 2011 | -46.92% |
| 2010 | -30.37% |
| 2009 | 85.97% |
| 2008 | 0.00% |
Prezzo dell'azione per aziende simili o concorrenti
| Azienda | Prezzo dell'azione | Variazione 1a% | Il paese |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $758.21 | 7.77% |
CH
|
